1. Abbruzzese and A Berardelli (2006) Neurophysiological effects of botulinum toxin type A.Neurotox. Res. 9, 109–114.
2. Adekar SP, MD Elias, KA Rybinski, F al-Saleem, AB Maksymowych, LL Simpson and SK Dessain (2006) Human antibodies that bind botulinum neurotoxin A.Neurotox. Res. 9, 243.
3. Aguilera J and C Gil (2006) Serotonergic action of tetanus toxin.Neurotox. Res. 9, 233.
4. Albanese A and G Brisinda (2006) Management of bladder, prostatic and pelvic floor disorders with botulinum neurotoxin.Neurotox. Res. 9, 222.
5. Aoki KR, A Satorius, C Ardila, M Brown, G Nicholson and J Francis (2006) Pharmacology of Botox®, Dysport®, Myobloc™ and BoNT/A in animal models of efficacy and safety.Neurotox. Res. 9, 236.